Organochalcogens affect the glutamatergic neurotransmission in human platelets

Neurochemical Research

Volumn 29, Issue 8, 2004, Pages 1505-1509

  Borges, V C ^a   Nogueira, C W ^a   Zeni, G ^a   Rocha, J B T ^b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b NONE

Author keywords

Glutamate; neurotoxicity; organoselenium; organotellurium; platelets

Indexed keywords

DIPHENYL DISELENIDE; DIPHENYL DITELLURIDE; DITHIOTHREITOL; EBSELEN; GLUTAMIC ACID; ORGANOHALOGEN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GABAERGIC SYSTEM; HUMAN; HUMAN CELL; NEUROTOXICITY; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN BINDING; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION;

EID: 84984585749     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000029562.56942.5d     Document Type: Article

References (38)

1. Chasteen, T. G. and Bentley, R. 2003. Biomethylation of selenium and tellurium: microorganisms and plants. Chem. Rev. 103:1-25.
2. Clark, R. F., Strukle, E., Willians, S. R., and Manoguerra, A. S. 1996. Selenium poisoning from a nutritional supplement. JAMA 275:1087-1088.
3. Gasmi, A., Garnier, R., Galliot-Guilley, M., Gaudillat, C., Quartenoud, B., Buisine, A., and Djebbar, D. 1997. Acute selenium poisoning. Vet. Hum. Toxicol. 39:30-1-308.
4. Patching, S. G. and Gardiner, P. H. E. 1999. Recent developments in selenium metabolism and chemical speciation: a review. Journal of Trace Elements in Medicine and Biology 13:193-214.
5. Navarro-Alarcon, M. and Lopez-Martinez, M. C. 2000. Essentiality of selenium in the human body: relationship with different diseases. Science of the Total Environment 249:347-371.
6. Ursini, F., Maiorino, M., Valente, M., Ferri, K., and Gregolin, C. 1982. Purification of pig liver of a protein which protects lipossomes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxidase. Biochem. Biophys. Acta 710:197-211.
7. Bock, A., Forchammer, J. H., Leinfelder, W., Sawers, G., Vepreck, B., and Zinnia, F. 1991. Selenocysteine: The 21st amino acid. Mol. Microbiol. 5:515-520.
8. Mugesh, G., du Mont, W. W., and Sies, H. 2001. Chemistry of biologically important organoselenium compounds. Chem. Rev. 101:2125-2179.
9. Stapleton, S. R., Garlock, G. L., Foellmi-Adams, L., and Kletzien, R. F. 1997. Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochim. Biophys. Acta 1355:259-269.
10. Larner, A. J. 1996. Alzheimer's disease, Kuf's disease, tellurium and selenium. Medical Hypotheses 47:73-75.
11. Lamer, A. J. 1995. Biological effects of tellurium: a review. Trace Elements and Electrolytes 12:26-31.
12. D'Gregorio, R. E. P., and Miller, R. K. 1988. Teratogenicity of tellurium dioxide. Teratology 37:307-316.
13. Gupta, N., and Porter, T. D. 2001. Garlic and garlic-derived compounds inhibit human squalene monooxygenase. J. Nutr. 131:1662-1667.
14. Kice, J. and Lee, T. W. S. 1978. Oxi-reduction of organoselenium compounds: part I. Mechanism of the reaction between seleninic acids and thiols. J. Am. Chem. Soc. 100:5094-5102.
15. Maciel, E. N., Bolzan, R. C., Braga, A. L., and Rocha, J. B. T. 2000. Diphenyl diselenide and diphenyl ditelluride differentially affects aminolevulinate dehydratase from liver, kidney and brain of mice. J. Biochem. Mol. Toxicol. 14:310-319.
16. Nogueira, C. W., Meotti, F. C., Curte, E. N., Pilissão, C., Zeni, G. Z., and Rocha, J. B. T. 2003. Investigations in the potential neurotoxicity induced by diselenides in mice and rats. Toxicology 183:29-37.
17. Nogueira, C. W., Rotta, L. N., Perry, M. L., Souza, D. O., and Rocha, J. B. T. 2001. Diphenyl diselenide and diphenyl ditelluride affect the rat glutamatergic system in vitro and in vivo. Brain Res. 906:157-163.
18. Nogueira, C. W., Rotta, L. N., Zeni, G., Souza, D. O., and Rocha, J. B. T. 2002. Exposure to Ebselen changes glutamate uptake and release by rat brain synaptosomes. Neurochem. Res. 3:283-288.
19. Daiber, A., Zhou, M., Bachscmid, M., and Ullrich, V. 2000. Ebselen as a peroxynitrite scavanger in vitro and ex vivo. Biochem. Pharmacol. 59:153-160.
20. Meotti, F. C., Borges, V. C., Zeni, G., Rocha, J. B. T., and Nogueira, C. W. 2003. Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and Ebselen for rats and mice. Toxicol. Lett. 143:9-16.
21. Pamham, M. J. and Graf, E. 1991. Pharmacology of synthetic organic selenium compounds. Prog. Drug Res. 36:9-47.
22. Nogueira, C. W., Quinhones, E. B., Jung, E. A. C., Zeni, G., and Rocha, J. B. T. 2003. Anti-inflammatory and antinociceptive activity of diphenyl diselenide. Inflamm. Res. 52:56-63.
23. Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T., and Yasuhara, H. 1998. Ebselen in acute ischaemic stroke: a placebo-controlled, double-blind clinical trial. Stroke 29:12-17.
24. Porciuncula, L. O., Rocha, J. B. T., Boeck, C. R., Vendite, D., and Souza, D. O. 2001. Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons. Neurosci. Lett. 299:217-220.
25. Rossato, J. I., Ketzer, L. A., Centurião, F. B., Silva, S. J. N., Lüdtke, D. S., Zeni, G., Braga, A. L., Rubin, M. A., and Rocha, J. B. T. 2002. Antioxidant properties of new chalcogenides against lipid peroxidation in rat brain. Neurochem. Res. 27:297-303.
26. Rossato, J. I., Zeni, G., Mello, C. F., Rubin, M. A., Rocha, J. B. T. 2002. Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci. Lett. 3:137-141.
27. Mangano, R. M. and Schwarcz, R. 1981. The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate. J. Neurochem. 36:1067-1076.
28. Hourani, S. M. O. and Cusack, N. J. 1991. Pharmacological receptors on blood-platelets. Pharmacol. Rev. 43:243-298.
29. Odagaki, Y. and Koyama, T. 2002. Epinephrine- and thrombinstimulated high-affinity GTPase activity in platelet membranes from patients with psychiatric disorders. Psychiatry Res. 112:111-119.
30. Rainesalo, S., Keranen, T., Peltola, J., and Saransaari, P. 2003. Glutamate uptake in blood platelets from epileptic patients. Neurochem. Int. 43:389-392.
31. Paulmier, C. 1986. Synthesis and properties of selenides. Pages 84-116, in Baldwin, J. E. (ed.), Selenium reagents and intermediates in organic synthesis, Pergamon Press, Oxford.
32. Engman, L. 1989. Expedient synthesis of Ebselen and related compounds. J. Org. Chem. 54:2964-2966.
33. Chapman, A. G. Glutamate and epilepsy. Am. Soc. Nutr. Sci. 2000;1043S-1045S.
34. Price, D. L. 1999. New order from neurological disorders. Nature 399:A3-A5.
35. Painter, E. P. 1941. The chemistry and toxicity of selenium compounds with special reference to the selenium problem. Chem. Rev. 28:179-213.
36. Barbosa, N. B. V., Rocha, J. B. T., Zeni, G., Emanuelli, T., Beque, M. C., and Braga, A. L. 1998. Effect of organic forms of selenium on 5-aminolevulinate dehydratase from liver, kidney and brain of adult rats. Toxicol. Appl. Pharmacol. 149:243-253.
37. Danbolt, N. C. 2001. Glutamate uptake. Prog. Neurobiol. 1:1-105.
38. 2+ influx into brain synaptosomes. J. Biochem. Mol. Toxicol. 17:154-160.